Dilt-XR and Olanzapine and Fluoxetine Capsules
Determining the interaction of Dilt-XR and Olanzapine and Fluoxetine Capsules and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:FLUoxetine may increase the blood levels and effects of dilTIAZem. You may be more likely to experience serious side effects such as irregular heart rhythm, fluid retention, swelling, heart failure, and excessively low blood pressure. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. You should seek medical attention if you develop dizziness or fainting; sudden, unexplained weight gain; swelling of the hands, ankles, or feet; chest pain; or difficulty breathing during treatment with these medications. Avoid driving or operating hazardous machinery until you know how the medications affect you, and use caution when getting up from a sitting or lying position. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration of fluoxetine with calcium channel blockers may increase their plasma concentrations and the risk of side effects. The mechanism is reduced clearance of the calcium channel blocker due to inhibition of CYP450 3A4-mediated metabolism by fluoxetine. Reports exist for nifedipine, nimodipine, and verapamil. Theoretically, the interaction may also occur with other calcium channel blockers that are CYP450 3A4 substrates.
MANAGEMENT: Monitoring of clinical response and tolerance, including blood pressure, is recommended if fluoxetine is used in combination with calcium channel blockers that are metabolized by CYP450 3A4. Dose reductions may be considered, if necessary. Patients should be advised to seek medical attention if they experience edema or swelling of the lower extremities; sudden, unexplained weight gain; difficulty breathing; chest pain or tightness; or hypotension as indicated by dizziness, fainting, or orthostasis.
- "Product Information. Nimotop (nimodipine)." Bayer, West Haven, CT.
- Canadian Pharmacists Association "e-CPS. Available from: URL: http://www.pharmacists.ca/function/Subscriptions/ecps.cfm?link=eCPS_quikLink."
- "Product Information. Adalat (nifedipine)." Bayer, West Haven, CT.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Cerner Multum, Inc. "Australian Product Information." O 0
Generic Name: diltiazem
Brand name: Cardizem CD, Cartia XT, Dilt-XR, Diltia XT, Taztia XT, Tiazac, Cardizem, Dilacor XR, Dilt-CD, Diltzac, Matzim LA, Tiazac, Cardizem LA, Tiazac Extended Release Capsules
Synonyms: n.a.
Generic Name: fluoxetine / olanzapine
Brand name: Symbyax
Synonyms: Fluoxetine and olanzapine, Olanzapine and Fluoxetine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dilt-XR-Olanzapine Extended-Release Injection
- Dilt-XR-Olanzapine injection
- Dilt-XR-Olanzapine Intramuscular
- Dilt-XR-Olanzapine Orally Disintegrating Tablets
- Dilt-XR-Olanzapine Tablets
- Dilt-XR-Olanzapine, Olanzapine Pamoate
- Olanzapine and Fluoxetine Capsules-Diltia XT
- Olanzapine and Fluoxetine Capsules-Diltiazem
- Olanzapine and Fluoxetine Capsules-Diltiazem 12-Hour Sustained-Release Capsules
- Olanzapine and Fluoxetine Capsules-Diltiazem CD
- Olanzapine and Fluoxetine Capsules-Diltiazem Extended Release Tablets
- Olanzapine and Fluoxetine Capsules-Diltiazem Hydrochloride